Adipose triglyceride lipase: A new target in the regulation of lipolysis by insulin

Current Diabetes Reviews

Volumn 7, Issue 4, 2011, Pages 270-277

  Chakrabarti, Partha ^a   Kandror, Konstantin V ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ATGL; Gene expression; Insulin; Lipolysis; Type 2 diabetes

Indexed keywords

FATTY ACID; INSULIN; INTERFERON REGULATORY FACTOR 4; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; ARTICLE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME REGULATION; GENE IDENTIFICATION; GENE SWITCHING; HUMAN; INSULIN RESISTANCE; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ADIPOSE TISSUE; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INSULIN; LIPASE; LIPOLYSIS;

EID: 79961002859     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339911796397866     Document Type: Article

References (97)

1. Wells JC. The evolution of human fatness and susceptibility to obesity: an ethological approach. Biol Rev Camb Philos Soc 2006; 81: 183-205.
2. Bellisari A. Evolutionary origins of obesity. Obes Rev 2008; 9: 165-180.
3. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 2004; 279: 48968-48975.
4. Zimmermann R, Strauss JG, Haemmerle G, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004; 306: 1383-6.
5. Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis sqa highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011; 50: 14-27.
6. Yang X, Lu X, Lombes M, et al. The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab 2010; 11: 194-205.
7. Villena JA, Roy S, Sarkadi-Nagy E, Kim KH, Sul HS. Desnutrin, an adipocyte gene encoding a novel patatin domain-containing pro-tein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem 2004; 279: 47066-75.
8. Ahmadian M, Wang Y, Sul HS. Lipolysis in adipocytes. Int j Bio-chem Cell Biol 2010; 42: 555-9.
9. Watt MJ, Spriet LL. Triacylglycerol lipases and metabolic control: implications for health and disease. Am J Physiol Endocrinol Metab 2010; 299: E162-8.
10. Nye C, Kim J, Kalhan SC, Hanson RW. Reassessing triglyceride synthesis in adipose tissue. Trends Endocrinol Metab 2008;19: 356-61.
11. Turban S, Hajduch E. Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance. FEBS Lett 2011; 585: 269-74.
12. Carmen GY, Victor SM. Signalling mechanisms regulating lipoly-sis. Cell Signal 2006; 18: 401-8.
13. Bastie CC, Nahle Z, McLoughlin T, et al. FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and -independent mechanisms. J Biol Chem 2005; 280: 14222-9.
14. Gauthier MS, Miyoshi H, Souza SC, et al. AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J Biol Chem 2008; 283: 16514-24.
15. Miyoshi H, Perfield JW, 2nd, Souza SC, et al. Control of adipose triglyceride lipase action by serine 517 of perilipin A globally regulates protein kinase A-stimulated lipolysis in adipocytes. J Biol Chem 2007; 282: 996-1002.
16. Watt MJ, Steinberg GR. Regulation and function of triacylglycerol lipases in cellular metabolism. Biochem J 2008; 414: 313-25.
17. Sztalryd C, Xu G, Dorward H, et al. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J Cell Biol 2003; 161: 1093-103.
18. Song Y, Altarejos J, Goodarzi MO, et al. CRTC3 links catechola-mine signalling to energy balance. Nature 2010; 468: 933-9
19. Altarejos JY, Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 2011; 12: 141-51.
20. Choi YH, Park S, Hockman S, et al. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice. J Clin Invest 2006; 116: 3240-51.
21. Kitamura T, Kitamura Y, Kuroda S, et al. Insulin-induced phos-phorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol 1999; 19: 6286-96.
22. Oknianska A, Zmuda-Trzebiatowska E, Manganiello V, Degerman E. Long-term regulation of cyclic nucleotide phosphodiesterase type 3B and 4 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2007; 353: 1080-5.
23. Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr 2007; 27: 79- 101.
24. Choi SM, Tucker DF, Gross DN, et al. Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway. Mol Cell Biol 2010; 30: 5009-20.
25. Chakrabarti P, Kandror KV. FoxO1 controls insulin-dependent ATGL expression and lipolysis in adipocytes. J Biol Chem 2009; 284: 13296-300
26. Chakrabarti P, English T, Shi J, Smas CM, Kandror KV. Mammal-ian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes 2010; 59: 775-81.
27. Eguchi J, Wang X, Yu S, et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metab 201; 13: 249-59.
28. Narbonne P, Roy R. Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival. Nature 2009; 457: 210-4.
29. Gronke S, Mildner A, Fellert S, et al. Brummer lipase is an evolu-tionary conserved fat storage regulator in Drosophila. Cell Metab 2005; 1: 323-30.
30. yeast: triglyceride lipolysis is functionally conserved from mammals to yeast. J Biol Chem 2006; 281: 491-500.
31. Eastmond PJ. SUGAR-DEPENDENT1 encodes a patatin domain triacylglycerol lipase that initiates storage oil breakdown in germinating arabidopsis seeds. Plant Cell 2006; 18: 665-75.
32. Haemmerle G, Lass A, Zimmermann R, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734-7.
33. Zechner R, Kienesberger PC, Haemmerle G, Zimmermann R, Lass A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res 2009; 50: 3-21.
34. Ahmadian M, Duncan RE, Varady KA, et al. Adipose overexpres-sion of desnutrin promotes fatty acid utilization and attenuates diet- induced obesity. Diabetes 2009; 58: 855-66
35. Fischer J, Lefevre C, Morava E, et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet 2007; 39: 28-30.
36. Akiyama M, Sakai K, Ogawa M, McMillan JR, Sawamura D, Shimizu H. Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy. Muscle Nerve 2007; 36: 856-9.
37. Kobayashi K, Inoguchi T, Maeda Y, et al. The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets. J Clin Endocrinol Metab 2008; 93: 2877-84.
38. Arner P, Langin D. The role of neutral lipases in human adipose tissue lipolysis. Curr Opin Lipidol 2007; 18: 246-50.
39. Subramanian V, Rothenberg A, Gomez C, et al. Perilipin A medi-ates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J Biol Chem 2004; 279: 42062-71.
40. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidyli-nositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006; 7: 606-19.
41. Lefevre C, Jobard F, Caux F, et al. Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet 200; 69: 1002-12.
42. Chanarin I, Patel A, Slavin G, Wills EJ, Andrews TM, Stewart G. Neutral-lipid storage disease: a new disorder of lipid metabolism. Br Med J 1975; 1: 553-5.
43. Dorfman ML, Hershko C, Eisenberg S, Sagher F. Ichthyosiform dermatosis with systemic lipidosis. Arch Dermatol 1974; 110: 261-266.
44. Yamaguchi T, Osumi T. Chanarin-Dorfman syndrome: deficiency in CGI-58, a lipid droplet-bound coactivator of lipase. Biochim Biophys Acta 2009; 1791: 519-23.
45. Zandbergen F, Mandard S, Escher P, et al. The G0/G1 switch gene 2 is a novel PPAR target gene. Biochem J 2005; 392: 313-24
46. Bartz R, Zehmer JK, Zhu M, et al. Dynamic activity of lipid drop-lets: protein phosphorylation and GTP-mediated protein translocation. J Proteome Res 2007; 6: 3256-65.
47. Kim JY, Tillison K, Lee JH, Rearick DA, Smas CM. The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for trans- activation by PPARgamma. Am J Physiol Endocrinol Metab 2006; 29: E115-27.
48. Kershaw EE, Hamm JK, Verhagen LA, Peroni O, Katic M, Flier JS. Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes 2006; 55: 148-57.
49. Kralisch S, Klein J, Lossner U, et al. Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Mol Cell Endocrinol 2005; 240: 43-9.
50. Nielsen R, Pedersen TA, Hagenbeek D, et al. Genome-wide profil-ing of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev 2008; 22: 2953-67.
51. Festuccia WT, Laplante M, Berthiaume M, Gelinas Y, Deshaies Y. PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia 2006; 49: 2427-36.
52. Kershaw EE, Schupp M, Guan HP, Gardner NP, Lazar MA, Flier JS. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metab 2007; 293: E1736-45.
53. Lee CH, Kang K, Mehl IR, et al. Peroxisome proliferator-activated receptor delta promotes very low-density lipoprotein-derived fatty acid catabolism in the macrophage. Proc Natl Acad Sci U S A 2006; 103: 2434-9.
54. Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci. 2007; 120: 2479-87.
55. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004; 117: 421-6
56. Nakae J, Kitamura T, Kitamura Y, Biggs WH, 3rd, Arden KC, Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 2003; 4: 119-29.
57. Nakae J, Biggs WH, 3rd, Kitamura T, et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 2002; 32: 245-53.
58. Kim JJ, Li P, Huntley J, Chang JP, Arden KC, Olefsky JM. FoxO1 haploinsufficiency protects against high fat diet-induced insulin resistance with enhanced PPAR{gamma} activation in adipose tissue. Diabetes 2009; 58: 1275-82.
59. Dowell P, Otto TC, Adi S, Lane MD. Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling path- ways. J Biol Chem 2003; 278: 45485-91.
60. Fan W, Imamura T, Sonoda N, et al. FOXO1 transrepresses perox-isome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes. J Biol Chem 2009; 284: 12188-97.
61. Armoni M, Harel C, Karni S, et al. FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. J Biol Chem 2006; 281: 19881-91.
62. Nakae J, Cao Y, Oki M, et al. Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure. Diabetes 2008; 57: 563-76.
63. Jing E, Gesta S, Kahn CR. SIRT2 regulates adipocyte differentia-tion through FoxO1 acetylation/deacetylation. Cell Metab 2007; 6: 105-14.
64. Wang F, Tong Q. SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma. Mol Biol Cell 2009; 20: 801-8.
65. Picard F, Kurtev M, Chung N, et al. Sirt1 promotes fat mobiliza-tion in white adipocytes by repressing PPAR-gamma. Nature 2004; 429: 771-6.
66. Frescas D, Valenti L, Accili D. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem 2005; 280: 20589-95.
67. Eguchi J, Yan QW, Schones DE, et al. Interferon regulatory factors are transcriptional regulators of adipogenesis. Cell Metab 2008; 7: 86-94.
68. Bhaskar PT, Hay N. The two TORCs and Akt. Dev Cell 2007; 12: 487-502.
69. Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 2008; 412: 179-90.
70. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124: 471-84.
71. Kim JE, Chen J. Regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 2004; 53: 2748-56.
72. Yeh WC, Bierer BE, McKnight SL. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad Sci U S A 1995; 92: 11086-90.
73. Cho HJ, Park J, Lee HW, Lee YS, Kim JB. Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem Biophys Res Commun 2004; 321: 942-8.
74. Sarbassov DD, Ali SM, Sengupta S, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 2006; 22: 159-68.
75. Luong N, Davies CR, Wessells RJ, et al. Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity. Cell Metab 2006; 4: 133-42.
76. Teleman AA, Chen YW, Cohen SM. Drosophila melted modulates FOXO and TOR activity. Dev Cell 2005; 9: 271-81.
77. Teleman AA, Chen YW, Cohen SM. 4E-BP functions as a meta-bolic brake used under stress conditions but not during normal growth. Genes Dev 2005; 19: 1844-8.
78. Blackshear PJ, Stumpo DJ, Carballo E, Lawrence JC, Jr. Disruption of the gene encoding the mitogen-regulated translational modulator PHAS-I in mice. J Biol Chem 1997; 272: 31510-4.
79. Tsukiyama-Kohara K, Poulin F, Kohara M, et al. Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med 2001; 7: 1128-32.
80. Le Bacquer O, Petroulakis E, Paglialunga S, et al. Elevated sensi-tivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J Clin Invest 2007; 117: 387-96.
81. Cohen MD. Genitourinary tumors. In: Cohen MD, Ed. Imaging of Children with Cancer. Mosby Elsevier Health Science: 1992: pp. 552-88.
82. Bissler JJ, Kingswood JC. Renal angiomyolipomata. Kidney Int 2004; 66: 924-34.
83. Porstmann T, Santos CR, Griffiths B, et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 2008; 8: 224-36.
84. Polak P, Cybulski N, Feige JN, Auwerx J, Ruegg MA, Hall MN. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 2008; 8: 399-410.
85. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007; 450: 736-40.
86. Bentzinger CF, Romanino K, Cloetta D, et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 2008; 8: 411-424.
87. Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev 2005; 19: 1773-8.
88. Harvey KF, Mattila J, Sofer A, et al. FOXO-regulated transcription restricts overgrowth of Tsc mutant organs. J Cell Biol 2008; 180: 691-6.
89. Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven GM. Ambient plasma free fatty acid concentrations in noninsulin- dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 1985; 61: 807-11.
90. Abbasi F, McLaughlin T, Lamendola C, Reaven GM. Insulin regu-lation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance. Metabolism 2000; 49: 151-4.
91. Reaven GM, Chang H, Hoffman BB. Impaired insulin-mediated inhibition of lipolysis and glucose transport with aging. Horm Me- tab Res 1989; 21: 168-71.
92. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51: 7-18.
93. McGarry JD. What if minkowski had been ageusic? An alternative angle on diabetes. Science 1992; 258: 766-70.
94. Wolf G. Calorie restriction increases life span: a molecular mecha-nism. Nutr Rev 2006; 64: 89-92.
95. Wang MC, O'Rourke EJ, Ruvkun G. Fat metabolism links germline stem cells and longevity in C. elegans. Science 2008; 322: 957-60
96. Xie T. Physiology. Burn fat, live longer. Science 2008; 322: 865-6
97. Kenyon CJ. The genetics of ageing. Nature 2010; 464: 504-12